Bringing Biofabrication Companies Together
The Advanced Regenerative Manufacturing Institute (ARMI) is leading the charge in revolutionizing the bioeconomy of the United States. As a member-based nonprofit, ARMI operates through its flagship initiative, BioFabUSA, which fosters collaboration among more than 200 partners, including corporations, academic institutions, and nonprofits. The goal: to develop scalable, consistent, and cost-effective manufacturing processes for engineered tissues and organs.
Through BioFabUSA, ARMI is at the forefront of integrating cutting-edge innovations in cell and tissue culture with advancements in biofabrication, automation, robotics, and analytical technologies. This ambitious initiative aims to transform the landscape of healthcare by enabling the mass production of engineered tissues, bringing regenerative medicine closer to mainstream clinical application.
The Groundbreaking Tissue Foundry
At the core of ARMI’s efforts is the Tissue Foundry, a pioneering platform that represents the first-ever scalable, modular, and automated biofabrication system. Designed to streamline the manufacturing of cell-based products, the Tissue Foundry features various subsystems that correspond to different stages of the biofabrication process.
The platform’s modular nature allows for scalability and adaptability, making it capable of producing a wide range of tissue products. By integrating automation and closed-system design, ARMI enhances efficiency, reduces contamination risks, and ensures high-quality production standards for regenerative medicine applications.
A Collaborative Future in Biofabrication for setting Standards
ARMI’s efforts are instrumental in bridging the gap between laboratory research and large-scale production, accelerating the transition of regenerative medicine from experimental stages to practical, life-saving applications. With its vast network of industry and academic partners, the organization continues to push the boundaries of what is possible in biofabrication.
Check out the video for more info:




Leave a comment